GLP-1 Drugs May Cut Heart and Stroke Risk in Diabetics
GLP-1 Drugs May Cut Heart and Stroke Risk in Diabetics Researchers have found that GLP-1 drugs, such as Ozempic and Mounjaro, which are often prescribed for weight loss, appear to be more effective in lowering heart disease risks among people with type 2 diabetes than many other glucose-lowering medications. Experts explain that these medications work…
